Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00968097
Recruitment Status : Terminated (Early Phase I study of [123I]MNI-340 did not evidence as marker of disease)
First Posted : August 28, 2009
Last Update Posted : April 3, 2019
Sponsor:
Information provided by (Responsible Party):
Institute for Neurodegenerative Disorders

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 2008
Actual Study Completion Date : July 2008